Struggling diagnostics company Provalis is selling its remaining business in diabetes testing and will put itself into liquidation. Its shares tumbled from 0.75p to 0.32p after the company said it had ...

DEESIDE healthcare company Provalis has signed an exclusive deal to distribute a respiratory treatment drug in the UK and Ireland. DEESIDE healthcare company Provalis has signed an exclusive deal to ...

The healthcare group Provalis placed itself into voluntary liquidation yesterday after suffering problems with its new diabetes testing kit and running out of cash. It offering investors 0.4p a share ...

TWST: Could you start off by giving us a brief overview of Provalis including the company's history please Dr. Gould? Dr. Gould: Provalis was relaunched in the autumn of 1999 and is a ...

PHILIP GOULD joined Provalis PLC in January 1998 as Director of Research and Development and became Chief Executive Officer in January 1999. Prior to joining Provalis, he was head of new product ...

DEESIDE- based medical diagnostics and pharmaceuticals group Provalis has made the final payment to Pfizer for its osteo-arthritis treatment Diclomax. DEESIDE- based medical diagnostics and ...

HEALTHCARE company Provalis has been awarded £1.6m after arbitration over a disputed contract decided in its favour. HEALTHCARE company Provalis has been awarded #1.6m after arbitration over a ...

Medical diagnostics firm Provalis last night said a strong performance from its diabetes testing product had helped drive annual sales up by almost 50 per cent. The company, based in Deeside, ...

SHAREHOLDERS in Deeside-based healthcare company Provalis have approved the £10.5m sale of its pharmaceutical arm in a move that will give the company cash to enhance a medical diagnostic product.